Entrada Therapeutics, Inc. (TRDA)

Last Year

15-May-23 -- 14-May-24

Time Period:

$25.68K Net Amount

Buy:	$25.68K	$12.66 - $12.66
Sell:	0	--

Company Sentiment

Other

Other

Sentiment Breakdown by Insider

0

(3)

0

(2)

0

(1)

9

0

6

+1

0

+2

0

+3

Two Year Chart

15-May-22 -- 14-May-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
19-Mar-24 4:33 PM View:	15-Mar-24 Option Exercise $18.90K	Wentworth Kory James Chief Financial Officer		Entrada Therapeutics, Inc. - TRDA	197% 27.96K to 83.17K	0	0	--	--	Show Txns Hide Txns

06-Sep-23 5:08 PM View:	06-Sep-23 Sale (Planned) ($12.02K)	Kreher Nerissa Chief Medical Officer		Entrada Therapeutics, Inc. - TRDA	48% 27.13K to 40.04K	0	0	--	--	Show Txns Hide Txns

05-Mar-24 7:44 PM View:	05-Mar-24 Payment of Exercise ($18.48K)	Sethuraman Natarajan Chief Scientific Officer		Entrada Therapeutics, Inc. - TRDA	22% 171.32K to 209.03K	0	0	--	--	Show Txns Hide Txns

10-May-24 4:35 PM View:	09-May-24 Purchase $31.34K	Kim Peter S Director		Entrada Therapeutics, Inc. - TRDA	43% 47.04K to 67.41K	$25.68K 4%	0	$12.66 - $12.66	--	Show Txns Hide Txns

05-Mar-24 7:48 PM View:	05-Mar-24 Payment of Exercise ($62.00K)	Doshi Dipal CEO Director		Entrada Therapeutics, Inc. - TRDA	68% 202.07K to 340.38K	0	0	--	--	Show Txns Hide Txns

08-Mar-24 4:34 PM View:	06-Mar-24 Private Sale (Planned) ($22.50K)	Dowden Nathan J President & COO		Entrada Therapeutics, Inc. - TRDA	135% 58.45K to 137.2K	0	0	--	--	Show Txns Hide Txns